Additionally, γδ T cells have been reported to induce tumour killing of FAS- and TRAIL-receptor-sensitive cancers [44–46] to enhance the antibody-dependent cellular cytotoxicity (ADCC) (figure 1d) [44–48]. This evidence concerns the gene FAS and neoplasm.